Integrated Wellness Acquisition Corp

WELNFdata completeness 50%3 fiscal years on file

Data notes: no data for concept 'revenue'; no data for concept 'capex'; no data for concept 'totalDebt'; no data for concept 'dilutedShares'; no data for concept 'epsDiluted'; no data for concept 'interestExpense'; no data for concept 'incomeTaxExpense'; no data for concept 'pretaxIncome'

i. The business — what you’d actually own
FigureFY 2022FY 2023FY 2024
Revenue
Net income$567,5411$1.49M2−$100,0312
Operating cash flow−$37,2623$3.22M4$1.09M4
Capital expenditure
Free cash flow (derived)
Total debt
Cash & equivalents$436,9725$7,5676$5,1416
Diluted shares

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

iii. Is this a good business?
Moat signal · return on equity
avg · 3y

Not enough data in the filings for a return-on-capital reading.

seeing a moat in the numbers →
Management signal · capital allocation
shares · 3y

Not enough history to read capital allocation.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth —

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 10-K · period ending 2022-12-31 · accession 0001410578-24-000421 (NetIncomeLoss)
  2. 10-K · period ending 2023-12-31 · accession 0001410578-25-000739 (NetIncomeLoss)
  3. 10-K · period ending 2022-12-31 · accession 0001410578-24-000421 (NetCashProvidedByUsedInOperatingActivities)
  4. 10-K · period ending 2023-12-31 · accession 0001410578-25-000739 (NetCashProvidedByUsedInOperatingActivities)
  5. 10-K · period ending 2022-12-31 · accession 0001410578-24-000421 (CashAndCashEquivalentsAtCarryingValue)
  6. 10-K · period ending 2023-12-31 · accession 0001410578-25-000739 (CashAndCashEquivalentsAtCarryingValue)